FDA Inspection
Merck Serono S.p.A.Merck Serono S.p.A. – FDA Inspection, Jul 1, 2011
Record Details
This FDA Inspection record concerns Merck Serono S.p.A., with an inspection on July 1, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck Serono S.p.A.
- Inspection Date
- July 1, 2011
- Product Type
- Drugs
View Company Profile
ID · 8c4be201-1378-4541-a0bd-d94563ae2150
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 733934
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Merck Serono S.p.A.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2024 | Not classified | Office of Inspections and Investigations | |
| March 29, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Serono S.p.A.
- FDA Inspection 1276476 - 2024-07-11
- FDA Inspection 1159215 - 2019-03-29
- FDA Inspection 1024129 - 2017-07-28
- FDA Inspection 917646 - 2015-02-20
- FDA Inspection 824763 - 2013-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.